Serum Digoxin Levels Related to Plasma Propafenone Levels During Concomitant Treatment-Reference-Cited by-同舟云学术

Serum Digoxin Levels Related to Plasma Propafenone Levels During Concomitant Treatment

Published:1991-06 Issue:6 Volume:31 Page:521-526
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Bigot Marie-Claire,Debruyne Danièle,Bonnefoy Laurent,Grollier Gilles,Moulin Maurice,Potier Jean-Claude

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1552-4604.1991.tb03731.x/fullpdf

Reference11 articles.

1. Quinidine-digoxin interaction;Doering;N Engl J Med,1979

2. Interaction between digoxin and calcium antagonists and antiarrhythmic drugs;Belz;Clin Pharmacol Ther,1983

3. Double-blind placebo-controlled evaluation of propafenone in suppressing ventricular ectopic activity;Hodges;Am J Cardiol,1984

4. Influenza del propafenone sulla farmacocinetica della digossina somministrata per via orale: studio su voluntari sani;Cardaioli;G Ital Cardiol,1986

5. Interazione digoxina-propafenone: Valori e limiti del dosaggio plasmatico dei due farmaci;Palumbo;G Itai Cardiol,1986

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac K2P13.1 (THIK-1) two-pore-domain K+ channels: Pharmacological regulation and remodeling in atrial fibrillation;Progress in Biophysics and Molecular Biology;2019-07

2. Cardiovascular pharmacology of K2P17.1 (TASK-4, TALK-2) two-pore-domain K+ channels;Naunyn-Schmiedeberg's Archives of Pharmacology;2018-07-14

3. Inhibition of cardiac two-pore-domain K+ (K2P) channels – an emerging antiarrhythmic concept;European Journal of Pharmacology;2014-09

4. Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K+ (K2P) channels;European Journal of Pharmacology;2013-12

5. Successful Treatment of Propafenone, Digoxin and Warfarin Overdosage with Plasma Exchange Therapy and Rifampicin;Clinical Drug Investigation;2007